AU2003236684A1 - Regulation of secretory phospholipase a2 group iia - Google Patents

Regulation of secretory phospholipase a2 group iia

Info

Publication number
AU2003236684A1
AU2003236684A1 AU2003236684A AU2003236684A AU2003236684A1 AU 2003236684 A1 AU2003236684 A1 AU 2003236684A1 AU 2003236684 A AU2003236684 A AU 2003236684A AU 2003236684 A AU2003236684 A AU 2003236684A AU 2003236684 A1 AU2003236684 A1 AU 2003236684A1
Authority
AU
Australia
Prior art keywords
regulation
group iia
secretory phospholipase
phospholipase
secretory
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003236684A
Other languages
English (en)
Inventor
Birgit Andree
Peter Ellinghaus
Raimund Kast
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Publication of AU2003236684A1 publication Critical patent/AU2003236684A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C12N15/1137—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/005—Enzyme inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Rheumatology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Virology (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biochemistry (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Cardiology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2003236684A 2002-06-17 2003-06-04 Regulation of secretory phospholipase a2 group iia Abandoned AU2003236684A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10226934A DE10226934A1 (de) 2002-06-17 2002-06-17 Regulation der sPLA2G2A
DE10226934.3 2002-06-17
PCT/EP2003/005826 WO2003105900A1 (fr) 2002-06-17 2003-06-04 Regulation de spla2giia

Publications (1)

Publication Number Publication Date
AU2003236684A1 true AU2003236684A1 (en) 2003-12-31

Family

ID=29594583

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003236684A Abandoned AU2003236684A1 (en) 2002-06-17 2003-06-04 Regulation of secretory phospholipase a2 group iia

Country Status (3)

Country Link
AU (1) AU2003236684A1 (fr)
DE (1) DE10226934A1 (fr)
WO (1) WO2003105900A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI20105629A0 (fi) * 2010-06-03 2010-06-03 Estaja Oy Menetelmä lipidiaktivoituvien entsyymien peptidi-inhibiittoreiden valmistamiseksi ja menetelmällä valmistettuja peptidejä
WO2013067579A1 (fr) * 2011-11-07 2013-05-16 The University Of Queensland Molécules modulant l'adiposité et utilisations associées

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2793791B1 (fr) * 1999-05-19 2002-01-25 Univ Paris 7 Denis Diderot Nouveaux composes inhibiteurs specifiques de phospholipases a2

Also Published As

Publication number Publication date
WO2003105900A1 (fr) 2003-12-24
DE10226934A1 (de) 2003-12-24

Similar Documents

Publication Publication Date Title
AU2003261405A1 (en) Regulation of transcription elongation factors
AU2003251973A1 (en) Controlling the characteristics of ribbon-shaped implanter ion-beams
AU2003259504A1 (en) Regulation of bi-directional flyback converter
AU2003250690A1 (en) Auto-characterization of optical devices
AU2003247951A1 (en) Compositions and methods for controlling parasitic nematodes
AU2003288686A1 (en) Compositions and systems for the regulation of genes
AU2003900810A0 (en) Method of scheduling
AU2003225088A1 (en) Regulation of tnf-alpha
AU2003277596A1 (en) Method of deuterization
AU2003255924A1 (en) Method of electrostatic deposition
AU2003256764A1 (en) Point of use lighting controller
AU2003205140A1 (en) Coated flaked fats
AU2003220609A1 (en) Temporary user suspension of automatic shutdown
AU2003216403A1 (en) Method for the recombination of genetic elements
AU2003248990A1 (en) Method of controlling scale formation
AU2003901316A0 (en) Regulation of cell surface proteins
AU2003236684A1 (en) Regulation of secretory phospholipase a2 group iia
AU2003249519A1 (en) Voltage regulator
AU2003292680A1 (en) Method of selecting novel immunosuppressant
AU2003268751A1 (en) Control method of generator
AU2003302352A1 (en) Method for increasing efficiency of thermotunnel devices
AU2003290763A1 (en) Modulation of jumonji expression
AU2003250329A1 (en) Regulation of novel human asparagine-hydroxylases
AU2003266271A1 (en) Regulation of human esterase
AU2002333290A1 (en) Regulator of calcineurin

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase